These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 30661495)
1. Genetic and Environmental Associations With Pediatric Cerebral Arteriopathy. McCrea N; Fullerton HJ; Ganesan V Stroke; 2019 Feb; 50(2):257-265. PubMed ID: 30661495 [No Abstract] [Full Text] [Related]
2. Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1. Santoro C; Giugliano T; Kraemer M; Torella A; Schwitalla JC; Cirillo M; Melis D; Berlit P; Nigro V; Perrotta S; Piluso G PLoS One; 2018; 13(7):e0200446. PubMed ID: 30001348 [TBL] [Abstract][Full Text] [Related]
3. ACTA2 Cerebral Arteriopathy: Not Just a Puff of Smoke. Cuoco JA; Busch CM; Klein BJ; Benko MJ; Stein R; Nicholson AD; Marvin EA Cerebrovasc Dis; 2018; 46(3-4):161-171. PubMed ID: 30300893 [TBL] [Abstract][Full Text] [Related]
4. Moyamoya disease and moyamoya syndrome. Scott RM; Smith ER N Engl J Med; 2009 Mar; 360(12):1226-37. PubMed ID: 19297575 [No Abstract] [Full Text] [Related]
6. Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West. Raso A; Biassoni R; Mascelli S; Nozza P; Ugolotti E; Di Marco E; De Marco P; Merello E; Cama A; Pavanello M; Capra V J Neurosurg Sci; 2020 Apr; 64(2):165-172. PubMed ID: 27787485 [TBL] [Abstract][Full Text] [Related]
7. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1. Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809 [TBL] [Abstract][Full Text] [Related]
8. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Amlie-Lefond C; Bernard TJ; Sébire G; Friedman NR; Heyer GL; Lerner NB; DeVeber G; Fullerton HJ; Circulation; 2009 Mar; 119(10):1417-23. PubMed ID: 19255344 [TBL] [Abstract][Full Text] [Related]
9. Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis. Okazaki S; Morimoto T; Kamatani Y; Kamimura T; Kobayashi H; Harada K; Tomita T; Higashiyama A; Takahashi JC; Nakagawara J; Koga M; Toyoda K; Washida K; Saito S; Takahashi A; Hirata M; Matsuda K; Mochizuki H; Chong M; Paré G; O'Donnell M; Ago T; Hata J; Ninomiya T; Dichgans M; Debette S; Kubo M; Koizumi A; Ihara M Circulation; 2019 Jan; 139(2):295-298. PubMed ID: 30615506 [No Abstract] [Full Text] [Related]
10. Intracranial arteriopathy in tuberous sclerosis complex. Boronat S; Shaaya EA; Auladell M; Thiele EA; Caruso P J Child Neurol; 2014 Jul; 29(7):912-9. PubMed ID: 24056157 [TBL] [Abstract][Full Text] [Related]
11. Moyamoya: epidemiology, presentation, and diagnosis. Smith ER; Scott RM Neurosurg Clin N Am; 2010 Jul; 21(3):543-51. PubMed ID: 20561502 [TBL] [Abstract][Full Text] [Related]
12. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Braun KP; Bulder MM; Chabrier S; Kirkham FJ; Uiterwaal CS; Tardieu M; Sébire G Brain; 2009 Feb; 132(Pt 2):544-57. PubMed ID: 19039009 [TBL] [Abstract][Full Text] [Related]
13. Structural causes of ischemic and hemorrhagic stroke in children: moyamoya and arteriovenous malformations. Smith ER Curr Opin Pediatr; 2015 Dec; 27(6):706-11. PubMed ID: 26474344 [TBL] [Abstract][Full Text] [Related]
14. Clinical Presentation and Stroke Incidence Differ by Moyamoya Etiology. Gatti JR; Torriente AG; Sun LR J Child Neurol; 2021 Mar; 36(4):272-280. PubMed ID: 33155871 [TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis type 1 associated with moyamoya syndrome in children. Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170 [TBL] [Abstract][Full Text] [Related]
16. How commonly do children with complex cerebral arteriopathy have renovascular disease? Willsher A; Roebuck DJ; Ng J; Ganesan V Dev Med Child Neurol; 2013 Apr; 55(4):335-40. PubMed ID: 23253043 [TBL] [Abstract][Full Text] [Related]
17. Familial occurrence of intracranial arterial occlusive disease (Moyamoya) in neurofibromatosis. Erickson RP; Woolliscroft J; Allen RJ Clin Genet; 1980 Sep; 18(3):191-6. PubMed ID: 6777096 [No Abstract] [Full Text] [Related]
18. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience. Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438 [TBL] [Abstract][Full Text] [Related]
19. Clinical and Imaging Characteristics of Arteriopathy Subtypes in Children with Arterial Ischemic Stroke: Results of the VIPS Study. Wintermark M; Hills NK; DeVeber GA; Barkovich AJ; Bernard TJ; Friedman NR; Mackay MT; Kirton A; Zhu G; Leiva-Salinas C; Hou Q; Fullerton HJ; AJNR Am J Neuroradiol; 2017 Nov; 38(11):2172-2179. PubMed ID: 28982784 [TBL] [Abstract][Full Text] [Related]
20. Spectrum of cerebral arteriopathies in children with arterial ischemic stroke. Rafay MF; Shapiro KA; Surmava AM; deVeber GA; Kirton A; Fullerton HJ; Amlie-Lefond C; Weschke B; Dlamini N; Carpenter JL; Mackay MT; Rivkin M; Linds A; Bernard TJ; Neurology; 2020 Jun; 94(23):e2479-e2490. PubMed ID: 32457211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]